Orchestra BioMed Inc. (OBIO) Business Metric Overview - Stocknear

Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
2.75
0.01 (0.36%)
At close: Sep 05, 2025, 3:59 PM
2.75
0.00%
After-hours: Sep 05, 2025, 06:47 PM EDT

Orchestra BioMed Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024
Product Revenue 169K 136K 326K 184K 150K 123K
Product Revenue Growth +24.26% -58.28% +77.17% +22.67% +21.95% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Selling, General, and Administrative Revenue 6.26M 6.26M 5.9M 5.67M 6.47M 5.82M 4.15M 6.34M 5.32M 4.41M 876.72K 813.41K 2.95M 2.48M 92.05K 94.44K 96.32K 111.95K
Selling, General, and Administrative Revenue Growth +0.02% +6.13% +4.15% -12.39% +11.06% +40.35% -34.60% +19.29% +20.56% +403.12% +7.78% -72.39% +18.89% +2592.16% -2.54% -1.94% -13.96% n/a
Research and Development Revenue 13.85M 13.48M 10.97M 11.6M 11.13M 9.11M 8.51M 8.56M 8.5M 8.25M 7.54M 5.9M 5.03M 3.47M 3.53M 3.66M 2.64M 3.06M
Research and Development Revenue Growth +2.75% +22.89% -5.38% +4.22% +22.10% +7.06% -0.55% +0.69% +2.97% +9.43% +27.87% +17.30% +44.76% -1.61% -3.50% +38.76% -13.91% n/a